1. Introduction
Quality of life (QOL) is defined by the World Health Organization as “individuals” perception of their position in life in relation to their goals, expectations, standards, and concerns as well as in the context of the culture and value systems in which they live [
1]. The QOL is influenced by a person’s physical and mental well-being, degree of independence, social connections, personal beliefs, and interactions with prominent elements of their environment. Since the mid-20th century, QOL has been a point of interest for many researchers and clinicians in various health and physiological well-being issues. The menopause is not exempt from this, due to the increase in life expectancy, the importance of women’s health in terms of this period of life being as important as the reproductive period.
The term “menopause” refers to the natural end of a woman’s ability to conceive, which can also be artificially caused through bilateral oophorectomy, which may or may not involve the removal of the uterus and fallopian tubes [
2]. Both types of menopause in women are characterized by low plasma levels, low concentrations of estradiol and progesterone in the brain, and a significant increase in follicle-stimulating hormone (FSH) levels [
3].
This likely affects several brain neurotransmitter systems and some peripheral physiological processes, affecting women’s QOL [
3,
4]. Moreover, the long-term absence of steroid hormones is associated with physiological changes that predispose women to urogenital, cardiovascular, bone, and mood disorders [
3]. While such changes occur gradually and require a long time to stabilize in natural menopause, they establish in a shorter time in surgical menopause, thus affecting the severity of symptoms compared to natural menopause [
3,
5,
6,
7].
However, in both cases, the typical symptoms associated with menopause significantly affect women’s QOL [
8]. This study is an attempt to explore the differences in QOL between women with natural and surgical menopause. The novelty of this study was that this was the first study in Greece that approached this topic.
2. Materials and Methods
2.1. Design of the Study
The data in this study were primary, as they were collected by the researcher for the first time. Purposive sample of female patients of one hospital in Greece was applied as the sampling method. In this study, the method of data collection was carried out using a questionnaire in printed form, which was completed by patients who attended the hospital for several reasons (routine screening, follow-up, etc.), after giving informed consent. The necessary condition for the participants to be in natural or surgical menopause constitutes the inclusion criterion. On the other hand, in the case of surgical menopause, the main criterion of exclusion was that the surgery was performed because of a malignancy.
2.2. Ethical Issues
The study was conducted in accordance with the Declaration of Helsinki and approved by Rea Maternity Hospital in Athens, Greece, and the Midwifery Department of the University of West Attica with ethics approval number 1820/11-11-2023. The date of approval was 11 November 2023.
2.3. Research Tool
After searching the literature, no validated questionnaire was found to meet the needs of this study. Thus, a questionnaire was redesigned, but it was based on similar questions from other studies or literature [
5,
6,
9,
10,
11] regarding sociodemographic data and medical history. The questionnaire was anonymous, and patients participated voluntarily. The questionnaire recorded the socio-demographic and anthropometric characteristics of the patients, the general health status of the patients, and the medical gynecological history of each patient. The Utian QOL Scale (UQOL) was used to assess patients’ QOL [
12,
13,
14,
15]. The Utian scale is a tool used to measure QOL in menopausal women; the reliability and validity of the instrument were assessed and published [
12]. Every question on the UQOL had a five-point Likert-type score, and the question scores in each domain were added to create the domain scores. It is a self-administered psychometric instrument that includes 23 questions related to 4 distinct but interrelated dimensions of QOL (occupational, health, sexual and emotional). This scale is always administered with a questionnaire recording menopausal symptoms.
2.4. Statistical Analysis
The sample size was calculated by G-Power, version 3.1.9.7 (University of Düsseldorf, Düsseldorf, Germany) in order to have statistically significant results. The mean and standard deviation (SD), as well as the median and interquartile range, were used to describe the quantitative variables, after appropriate testing of the normality of the distribution through the Kolmogorov–Smirnov statistical test, and the absolute (N) and relative frequency (%) were used to describe the qualitative variables. To compare the distribution of quantitative variables between two categories, the t-test for two independent samples was used.
Pearson’s X2 test was used for the correlation between two categorical variables, or Fisher’s exact test in some cases, due to not fulfilling the conditions of Pearson’s X2 test. The independent factors linked to the variables under investigation were identified using stepwise linear regression analysis in conjunction with linear regression analysis, yielding coefficients of dependency (β) and standard errors (SE). All tests performed were two-sided, and statistical significance was set at the level of p ≤ 0.05. SPSS v. 24.0 statistical package was used for statistical analysis and presentation of results.
3. Results
3.1. Demographics
The present study included 100 women, half of whom had natural menopause (N = 50), while the remaining (N = 50) women underwent surgical menopause. The mean age of the participants was 44.5 years (SD = 2.3 years), and the time period since the onset of menopause was approximately more than one year. Forty-six percent of the women were married, and in terms of employment status, at least 8 out of 10 women (81%) reported working, while 18% were unemployed. Also, as shown in
Table 1, there was a statistically significant difference in the age of participants according to their menopausal status, with women who had natural menopause being statistically significantly older (Mean = 46.0 years, SD = 1.6 years) compared to women who underwent surgical menopause (Mean = 43.0 years, SD = 1.8 years) (
p < 0.001) [
Table 1].
3.2. Anthropometric Characteristics
The participating women were, on average, 1.70 m tall and weighed 74.5 kg. Regarding their BMI, on average, it was equal to 27.2 kg/m
2, 36% of the women were of normal body weight, 33% were overweight, and 30% of the women were obese. However, no statistically significant difference was found according to the menopausal status [
Table 2].
3.3. Gynecological Characteristics
Eighty-one percent of the participants mentioned that the age of their first menstrual period was 12.2 years on average. Meanwhile, 67% of women reported that their menstrual periods were regular, while 50% of women reported having a uterus, cervix, and both ovaries. In addition, at least half of the women (56%) said they had breast examination. Finally, 22% of women had an abnormality on their Pap test, 31.3% had an abnormality on their mammogram, and 23.2% had an abnormality on their thyroid test. Furthermore, among women with natural menopause, those who have a uterus, those who have both ovaries, those who have a cervix, and those who had their breasts examined were statistically significantly higher than the percentage of women who have undergone surgical menopause. On the other hand, the proportion of women with regular menstrual periods was statistically significantly higher among women who underwent surgical menopause.
3.4. Health Profile
A total of 58% of participants experienced mood swings, 52% anxiety, 47% fatigue, and 40% of participants stated that their weight had increased. At the same time, at least 3 in 10 women said they had high blood pressure (hypertension) (38%), anemia (38%), muscle pain (35%), migraines (31%), arrhythmias (30%), and back pain (30%). Finally, there was a statistically significant difference in the percentage of women who gained weight, with this percentage being statistically significantly higher among women with natural menopause (50%), compared to the percentage of women who underwent surgical menopause (30%) (
p = 0.041) [
Table 3].
3.5. Menopausal Effect on Family Changes
The study found a statistically significant difference in the menopausal effect on family changes between the two participant groups, especially in the relationships between the family members and, in some cases, in the marital status. Specifically, women who had undergone surgical menopause had a statistically lower percentage of these changes than women who had undergone natural menopause [18 (36%) vs. 29 (58%), respectively] (p = 0.028).
3.6. Sexual Life
Although there are no statistically significant differences, it is important to highlight the high rates that the two groups have in terms of their sexual lives. More specifically, women who had naturally entered menopause showed concerns about their sexual life (85%), while 63% had lost interest in sexual activity. The same was true for the percentages of women who had surgery, with 64% having lost interest in sex, and 84% experiencing concerns about their sexual life. It was also found that women who have entered menopause either naturally or surgically have lost their ability to orgasm (88% vs. 92%) and during intercourse, they experience pain either from penile penetration, vaginal dryness, or vaginal pain.
3.7. Menopausal Symptoms
Both groups of women were affected by hot flashes whether their entry into menopause was natural (42%) or surgical (48%). This resulted in women in both groups having difficulty sleeping (38% vs. 36%), and lack of sleep created a constant fatigue that affected them in their daily lives (54% of women with natural menopause vs. 52% of women with surgical menopause). Moreover, women were found to be affected by estrogen deficiency, experiencing pain during intercourse (56%), lack of sexual interest (63% vs. 64%), and difficulty reaching orgasm (48% vs. 46%). Both groups of women show an alternation of emotions. A total of 57% of the patients showed several alternations, while 34% of them showed many alternations. Despite this high rate of emotional alternation, the women did not feel that their situation was bordering on depression.
3.8. QOL
Table 4 shows the participants’ scores on the UQOL according to their menopausal status. Higher scores indicate a better QOL. There was no statistically significant difference between the two groups [
Table 4].
3.9. Effect of Various Characteristics on Total QOL Assessment Scores
Regarding the effect of different participant characteristics on their overall score on the QOL assessment tool (after the sequential variable removal inclusion procedure), the results of multivariate linear regression on the effect showed that
- -
Women who exercise almost every day scored 16.41 points higher than participants who do not exercise, indicating that they have a better QOL (p < 0.001).
- -
A 1 kg/m increase in BMI was associated with a 0.78 point decrease in their score, indicating that participants of higher weight have a significantly worse QOL (p = 0.002).
- -
Women who have not used other menopause treatment methods score 5.54 points lower, indicating that they have a significantly worse QOL (
p = 0.018) [
Table 5]. Participants’ scores on the dimensions “Quality of Professional Life” and “Emotional QOL” were not found to be significantly correlated with women’s characteristics.
4. Discussion
Menopause is a condition that causes physical and psychological changes in women’s QOL due to estrogen deficiency [
16,
17]. Furthermore, surgical menopause causes a sudden drop in estrogen levels.
In contrast, a naturally menopausal woman goes through a phase of fluctuating hormone levels, and although the majority of these women report troublesome symptoms when asked, only some of them are related to the hormonal changes of the menopause transition. Evidence from other studies supports that surgical menopause, compared to natural menopause, is associated with more severe psychological and physical symptoms [
3,
5,
6,
7,
18].
However, our study found that the rates of menopause symptoms were significantly higher in both women who entered menopause naturally and women who underwent surgery. Our findings suggest that women, regardless of the type of menopause, suffered from severely different menopausal symptoms such as hot flushes, musculoskeletal and sweating symptoms, as well as depressed mood, anxiety, and sleep problems. Interestingly, despite that there is no statistical significance, our study indicated that in both groups, there was a high percentage of concerns about sexual life and lost interest in sexual activity. This result may be due to the significant decrease in estrogens that had an effect on vaginal dryness and painful intercourse (dyspareunia).
It is worth mentioning that urogenital symptoms including sexual problems, bladder problems, and vaginal dryness were less common in both groups. The individual and total UQOL scores were also low for the urogenital system, particularly more in women with surgical menopause, but the difference was not found to be statistically significant. This finding was also confirmed by the data in the study by Bhattacharya and Jha in 2010 [
5].
The only statistically significant difference found in our study was in weight gain, with women with natural menopause having a higher rate compared to women who underwent surgical menopause. This result is similar to other studies, which showed that overweight women have lower self-esteem and sometimes more health problems, affecting their QOL [
19,
20,
21,
22,
23].
In a multicentric cohort study called the Study of Women’s Health Across the Nation (SWAN) [
23], it was found that women who gained weight after menopause experienced more vasomotor symptoms or hot flashes, and consequently had lower QOL than those whose weight was unchanged.
In conclusion, postmenopausal women’s QOL, which is impacted by a variety of social and personal factors, is often impacted by menopause and accompanying symptoms. Therefore, appropriate interventions through public health policy aimed at mitigating the symptoms of menopause and maintaining the QOL. A limitation of the present study is that the results cannot be generalized, and larger studies are needed to confirm them.
5. Conclusions
Menopausal symptoms are associated with a decrease in women’s QOL. However, QOL is affected regardless of the type of menopause (natural menopause or surgical menopause). The present study suggests that, in the study population, the type of menopausal entry does not seem to show statistically significant differences in the occurrence of symptoms and QOL of women. Menopausal symptoms, psychosocial and sexual health, as well as the general health of the two groups, showed similar rates. The only statistically significant difference found was in weight gain, with women with natural menopause having a higher rate compared to women who underwent surgical menopause. Interestingly, despite that there is no statistical significance, our study indicated that in both groups, there was a high percentage of concerns about sexual life and lost interest in sexual activity. However, further studies in larger populations are needed to clarify whether surgical menopause may affect women’s QOL to a greater extent than natural menopause.
Author Contributions
Conceptualization, A.D. and A.B.; methodology, A.D. and F.K. software, F.K.; validation, F.K. and A.D.; formal analysis, F.K.; investigation, F.K.; resources, F.K. and A.B.; data curation, F.K., A.D. and A.B.; writing—original draft preparation, A.D. and A.B.; writing—review and editing, A.D. and A.B.; visualization, C.N., G.K. and V.V.; supervision, A.D.; project administration, F.K. All authors have read and agreed to the published version of the manuscript.
Funding
The APC was partially funded by the “Special Account for Research Grants” of the University of West Attica, Athens, Greece.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki and approved by Rea Maternity Hospital in Athens, Greece, and the Midwifery Department of the University of West Attica with ethics approval number 1820/11-11-2023. The date of approval was 11 November 2023.
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Public Involvement Statement
There was no public involvement in any aspect of this research.
Guidelines and Standards Statement
This manuscript was drafted against the Strengthening the Reporting of Observational studies (STROBE).
Use of Artificial Intelligence
AI or AI-assisted tools were used for language translation, language, editing, and grammar.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- Nazarpour, S.; Simbar, M.; Tehrani, F.R.; Majd, H.A. Factors associated with quality of life of postmenopausal women living in Iran. BMC Women’s Health 2020, 20, 104. [Google Scholar] [CrossRef] [PubMed]
- Chalkidou, A.; Oikonomou, E.; Lambrinos, D.; Bothou, A.; Kyriakou, D.; Nikolettos, K.; Marinos, G.; Iatrakis, G.; Zervoudis, S.; Nikolettos, N.; et al. The Comparative Study of the Administration of the Combination Preparation of Isoflavones and Hyaluronic Acid in Menopausal Women for the Treatment of the Symptoms of Menopause, Urogenital Atrophy and Osteoporosis in Relation to Existing Hormone Replacement Therapies. Mater. Sociomed. 2023, 35, 206–214. [Google Scholar] [CrossRef] [PubMed]
- Giannini, A.; Caretto, M.; Genazzani, A.R.; Simoncini, T. Neuroendocrine Changes during Menopausal Transition. Endocrines 2021, 2, 405–416. [Google Scholar] [CrossRef]
- Monteleone, P.; Mascagni, G.; Giannini, A.; Genazzani, A.R.; Simoncini, T. Symptoms of menopause—Global prevalence, physiology and implications. Nat. Rev. Endocrinol. 2018, 14, 199–215. [Google Scholar] [CrossRef]
- Bhattacharya, S.M.; Jha, A. A comparison of health-related quality of life (HRQOL) after natural and surgical menopause. Maturitas 2010, 66, 431–434. [Google Scholar] [CrossRef]
- Mahajan, N.; Kumar, D.; Fareed, P. Comparison of Menopausal Symptoms and Quality of Life after Natural and Surgical Menopause. Int. J. Sci. Stud. 2016, 3, 74–77. [Google Scholar]
- Kingsberg, S.A.; Larkin, L.C.M.; Liu, J.H.M. Clinical Effects of Early or Surgical Menopause. Obstet. Gynecol. 2020, 135, 853–868. [Google Scholar] [CrossRef]
- Schneider, H.P.G.; Birkhäuser, M. Quality of life in climacteric women. Climacteric 2017, 20, 187–194. [Google Scholar] [CrossRef]
- AlDughaither, A.; AlMutairy, H.; AlAteeq, M. Menopausal symptoms and quality of life among Saudi women visiting primary care clinics in Riyadh, Saudi Arabia. Int. J. Women’s Health 2015, 7, 645–653. [Google Scholar] [CrossRef]
- Velasco-Tellez, C.; Cortes-Bonilla, M.; Ortiz-Luna, G.; Sanchez-Zelayeta, L.; Mendez-Serrano, H.; Salazar-Jimenez, C.; Zavala-García, A.; Sánchez-Cevallos, A. Quality of Life and Menopause. In Quality of Life—Biopsychosocial Perspectives; Intechopen: London, UK, 2019. [Google Scholar]
- Demir, O.; Ozalp, M.; Sal, H.; Aran, T.; Osmanağaoğlu, M. The relationship of menopausal symptoms with the type of menopause and lipid levels. Menopausal Rev. 2020, 19, 6–10. [Google Scholar] [CrossRef]
- Utian, W.H.; Janata, J.W.; Kingsberg, S.A.; Schluchter, M.; Hamilton, J.C. The Utian Quality of Life (UQOL) Scale: Development and validation of an instrument to quantify quality of life through and beyond menopause. Menopause 2018, 25, 1224–1231. [Google Scholar] [CrossRef] [PubMed]
- Dotlic, J.; Gazibara, T.; Rancic, B.; Radovanovic, S.; Milosevic, B.; Kurtagic, I.; Nurkovic, S.; Kovacevic, N.; Utian, W. Translation and validation of the Utian Quality of Life Scale in Serbian peri- and postmenopausal women. Menopause 2015, 22, 984–992. [Google Scholar] [CrossRef] [PubMed]
- Pallikadavath, S.; Ogollah, R.; Singh, A.; Dean, T.; Dewey, A.; Stones, W. Natural menopause among women below 50 years in India: A population-based study. Indian J. Med. Res. 2016, 144, 366–377. [Google Scholar] [CrossRef] [PubMed]
- Wulandari, P.; Soeroso, Y.; Maharani, D.; Rahardjo, A. Validity and Reliability of a modified Utian Quality of Life Scale for In-donesian Postmenopausal Women. J. Int. Dent. Med. Res. 2018, 11, 232–237. [Google Scholar]
- Blumel, J.; Castelo-Branco, C.; Binfa, L.; Gramegna, G.; Tacla, X.; Aracena, B.; Cumsille, M.; Sanjuan, A. Quality of life after the menopause: A population study. Maturitas 2000, 34, 17–23. [Google Scholar] [CrossRef]
- Matthews, K.A.; Bromberger, J.T. Does the menopausal transition affect health-related quality of life? Am. J. Med. 2005, 118, 25–36. [Google Scholar] [CrossRef]
- Rodriguez-Landa, J.F.; Puga-Olguin, A.; German-Ponciano, L.J.; Garcia-Rios, R.I.; Soria-Fregozo, C. Anxiety in natural and surgical menopause: Physiologic and therapeutic bases. In A Fresh Look at Anxiety Disorders; Intechopen: London, UK, 2015; pp. 173–198. [Google Scholar]
- Kirchengast, S. Relations between anthropometric characteristics and degree of severity of the climacteric syndrome in Austrian women. Maturitas 1993, 17, 167–180. [Google Scholar] [CrossRef]
- Moilanen, J.M.; Aalto, A.-M.; Raitanen, J.; Hemminki, E.; Aro, A.R.; Luoto, R. Physical activity and change in quality of life during menopause -an 8-year follow-up study. Health Qual. Life Outcomes 2012, 10, 8. [Google Scholar] [CrossRef]
- Dennerstein, L.; Dudley, E.C.; Guthrie, J.R. Predictors of declining self-rated health during the transition to menopause. J. Psychosom. Res. 2003, 54, 147–153. [Google Scholar] [CrossRef]
- Sammel, M.D.; Grisso, J.A.; Freeman, E.W.; Hollander, L.; Liu, L.; Liu, S.; Nelson, D.B.; Battistini, M. Weight gain among women in the late reproductive years. Fam. Pract. 2003, 20, 401–409. [Google Scholar] [CrossRef]
- Thurston, R.C.; Sowers, M.R.; Chang, Y.; Sternfeld, B.; Gold, E.B.; Johnston, J.M.; Matthews, K.A. Adiposity and reporting of vasomotor symptoms among midlife women: The study of women’s health across the nation. Am. J. Epidemiol. 2007, 167, 78–85. [Google Scholar] [CrossRef] [PubMed]
Table 1.
Participant demographics.
Table 1.
Participant demographics.
| Total (N = 100) | Menopause Status | P-Pearson X2 Test |
---|
Natural (N = 50) | Surgical (N = 50) | |
---|
N (%) | N (%) | N (%) |
---|
Age (Years) [Mean (SD)] | 44.5 (2.3) | 46.0 (1.6) | 43.0 (1.8) | <0.001 1 |
Marital status | Unmarried | 16 (16.0) | 7 (14.0) | 9 (18.0) | 0.715 |
Married | 46 (46.0) | 21 (42.0) | 25 (50.0) |
Divorced | 22 (22.0) | 12 (24.0) | 10 (20.0) |
Widow | 4 (4.0) | 2 (4.0) | 2 (4.0) |
In symbiosis | 12 (12.0) | 8 (16.0) | 4 (8.0) |
Working status | Unemployed | 18 (18.0) | 10 (20.0) | 8 (16.0) | 0.539 |
Employee | 81 (81.0) | 40 (80.0) | 41 (82.0) |
Retired | 1 (1.0) | 0 (0.0) | 1 (2.0) |
Table 2.
Anthropometric characteristics among the women participating in the study.
Table 2.
Anthropometric characteristics among the women participating in the study.
| Total (N = 100) | Menopause Status | P-Independent Samples t-Test |
---|
Natural (N = 50) | Surgical (N = 50) |
---|
N (%) | N (%) | N (%) |
---|
Height (in meters) [Mean SD] | 1.7 (0.0) | 1.7 (0.1) | 1.7 (0.0) | 0.817 |
Weight (in kilograms) [Mean SD] | 74.5 (13.7) | 75.5 (15.2) | 73.4 (12.3) | 0.452 |
BMI (in kg/m2) [Mean SD] | 27.2 (4.5) | 27.6 (5.1) | 26.8 (3.9) | 0.355 |
Underweight | 1 (1.0) | 1 (2.0) | 0 (0.0) | 0.298 |
Normal body weight | 36 (36.0) | 18 (36.0) | 18 (36.0) |
Overweight | 33 (33.0) | 13 (26.0) | 20 (40.0) |
Obese | 30 (30.0) | 18 (36.0) | 12 (24.0) |
Table 3.
Health status of the women who participated in the study.
Table 3.
Health status of the women who participated in the study.
| Total | Menopause | P-Pearson X2 Test |
---|
Natural | Surgical |
---|
Ν (%) | Ν (%) | Ν (%) |
---|
Migraines | No | 69 (69.0) | 37 (74.0) | 32 (64.0) | 0.280 |
Yes | 31 (31.0) | 13 (26.0) | 18 (36.0) |
Fatigue | No | 53 (53.0) | 22 (44.0) | 31 (62.0) | 0.071 |
Yes | 47 (47.0) | 28 (56.0) | 19 (38.0) |
Blood pressure | No | 62 (62.0) | 31 (62.0) | 31 (62.0) | >0.999 |
Yes | 38 (38.0) | 19 (38.0) | 19 (38.0) |
Diarrhea | No | 76 (76.0) | 37 (74.0) | 39 (78.0) | 0.640 |
Yes | 24 (24.0) | 13 (26.0) | 11 (22.0) |
Sleepiness | No | 72 (72.0) | 36 (72.0) | 36 (72.0) | >0.999 |
Yes | 28 (28.0) | 14 (28.0) | 14 (28.0) |
Constipation | No | 91 (91.0) | 45 (90.0) | 46 (92.0) | 0.727 |
Yes | 9 (9.0) | 5 (10.0) | 4 (8.0) |
Dizziness | No | 81 (81.0) | 41 (82.0) | 40 (80.0) | 0.799 |
Yes | 19 (19.0) | 9 (18.0) | 10 (20.0) |
Arrhythmias | No | 70 (70.0) | 35 (70.0) | 35 (70.0) | >0.999 |
Yes | 30 (30.0) | 15 (30.0) | 15 (30.0) |
Mood swings | No | 42 (42.0) | 22 (44.0) | 20 (40.0) | 0.685 |
Yes | 58 (58.0) | 28 (56.0) | 30 (60.0) |
Muscle pains | No | 65 (65.0) | 35 (70.0) | 30 (60.0) | 0.95 |
Yes | 35 (35.0) | 15 (30.0) | 20 (40.0) |
Suicidal tendencies | No | 99 (99.0) | 49 (98.0) | 50 (100.0) | 0.315 |
Yes | 1 (1.0) | 1 (2.0) | 0 (0.0) |
Breast pains | No | 86 (86.0) | 42 (84.0) | 44 (88.0) | 0.564 |
Yes | 14 (14.0) | 8 (16.0) | 6 (12.0) |
Back pains | No | 70 (70.0) | 34 (68.0) | 36 (72.0) | 0.663 |
Yes | 30 (30.0) | 16 (32.0) | 14 (28.0) |
Hair loss | No | 96 (96.0) | 47 (94.0) | 49 (98.0) | 0.307 |
Yes | 4 (4.0) | 3 (6.0) | 1 (2.0) |
Varicose veins | No | 89 (89.0) | 44 (88.0) | 45 (90.0) | 0.749 |
Yes | 11 (11.0) | 6 (12.0) | 5 (10.0) |
Incontinence | No | 72 (72.0) | 32 (64.0) | 40 (80.0) | 0.075 |
Yes | 28 (28.0) | 18 (36.0) | 10 (20.0) |
Weight loss | No | 86 (86.0) | 43 (86.0) | 43 (86.0) | >0.999 |
Yes | 14 (14.0) | 7 (14.0) | 7 (14.0) |
Indigestion | No | 84 (84.0) | 45 (90.0) | 39 (78.0) | 0.102 |
Yes | 16 (16.0) | 5 (10.0) | 11 (22.0) |
Depression | No | 81 (81.0) | 41 (82.0) | 40 (80.0) | 0.799 |
Yes | 19 (19.0) | 9 (18.0) | 10 (20.0) |
Nausea and vomiting | No | 86 (86.0) | 45 (90.0) | 41 (82.0) | 0.249 |
Yes | 14 (14.0) | 5 (10.0) | 9 (18.0) |
Anxiety | No | 48 (48.0) | 28 (56.0) | 20 (40.0) | 0.109 |
Yes | 52 (52.0) | 22 (44.0) | 30 (60.0) |
Weight gain | No | 60 (60.0) | 25 (50.0) | 35 (70.0) | 0.041 |
Yes | 40 (40.0) | 25 (50.0) | 15 (30.0) |
Table 4.
QOL Scale (UQOL) score.
Table 4.
QOL Scale (UQOL) score.
| Menopause | P-Independent Samples t-Test |
---|
| Natural | Surgical |
---|
| Mean Value | SD | Mean Value | SD |
---|
Occupational | 22.6 | 5.1 | 23.0 | 5.2 | 0.727 |
Health | 20.0 | 5.9 | 21.5 | 5.2 | 0.181 |
Emotional | 14.9 | 3.6 | 16.2 | 4.4 | 0.120 |
Sexual | 6.2 | 2.7 | 6.0 | 2.8 | 0.715 |
Total | 63.7 | 11.6 | 66.6 | 13.4 | 0.248 |
Table 5.
Correlation between exercise frequency and Overall QOL.
Table 5.
Correlation between exercise frequency and Overall QOL.
Dependent Variable: “Overall QOL” | Dependence Coefficient (β) | Standard Error (SE) | p-Value |
---|
How often do you exercise? | | | |
Almost every day | 16.41 | 3.63 | <0.001 |
At least 3 times/week | 6.09 | 3.11 | 0.050 |
Occasionally | 3.13 | 3.48 | 0.369 |
Rarely | −2.29 | 3.85 | 0.552 |
BMI (per 1 kg/m2 increase) | −0.78 | 0.25 | 0.002 |
Have you used other menopause treatment methods? | | | |
Νο | −5.54 | 2.33 | 0.018 |
| Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).